Blincyto Interactions
There are 273 drugs known to interact with Blincyto (blinatumomab), along with 8 disease interactions. Of the total drug interactions, 63 are major, 187 are moderate, and 23 are minor.
- View all 273 medications that may interact with Blincyto
- View Blincyto disease interactions (8)
Most frequently checked interactions
View interaction reports for Blincyto (blinatumomab) and the medicines listed below.
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Avastin (bevacizumab)
- Baraclude (entecavir)
- Caprelsa (vandetanib)
- Corlanor (ivabradine)
- Cosentyx (secukinumab)
- Cymbalta (duloxetine)
- Entyvio (vedolizumab)
- Esbriet (pirfenidone)
- Imbruvica (ibrutinib)
- Isentress (raltegravir)
- Kalydeco (ivacaftor)
- Keppra (levetiracetam)
- Kynamro (mipomersen)
- Ofev (nintedanib)
- Pomalyst (pomalidomide)
- Procysbi (cysteamine)
- Prolia (denosumab)
- Pulmozyme (dornase alfa)
- Ravicti (glycerol phenylbutyrate)
- Repatha (evolocumab)
- Revlimid (lenalidomide)
- Sabril (vigabatrin)
- Soliris (eculizumab)
- Stivarga (regorafenib)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tecentriq (atezolizumab)
- Tecfidera (dimethyl fumarate)
- Thalomid (thalidomide)
Blincyto disease interactions
There are 8 disease interactions with Blincyto (blinatumomab) which include:
- vaccination
- leukoencephalopathy
- liver dysfunction
- metabolic acidosis
- neurologic disorders
- neutropenia
- pancreatitis
- renal impairment
Report options
More about Blincyto (blinatumomab)
- Blincyto consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Otrexup
Otrexup is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
Mercaptopurine
Mercaptopurine systemic is used for acute lymphoblastic leukemia, autoimmune hepatitis, crohn's ...
Dasatinib
Dasatinib is used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) ...
Doxorubicin
Doxorubicin systemic is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder ...
Imatinib
Imatinib is used to treat certain types of leukemia, bone marrow disorders, and skin cancer ...
Methotrexate
Methotrexate is used to treat certain types of cancer of the breast, skin, head and neck, or lung ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
